FDA Commissioner Criticizes COVID Booster Policy: 'No Data, No Trials, No Justification'

The FDA Commissioner's testimony on the 2026 budget request has sparked controversy, with Dr. Martin Makary raising serious concerns about the current COVID-19 booster policy. During the hearing, Dr. Makary stated, 'No Data, No Trials, No Justification – We’re Flying Blind,' highlighting the lack of evidence to support the policy's limitations. He questioned the decision to restrict booster access to those 65 and older or at high risk, arguing that this approach prevents individuals from making informed choices about their health. Dr. Makary's testimony underscores the need for greater transparency and evidence-based decision-making in public health policies. The video of the testimony has already garnered significant online attention, further demonstrating the public's interest in this critical issue. The FDA's response to these concerns will likely shape future COVID-19 vaccination strategies.